PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
60 hedge funds and large institutions have $1.44B invested in PRA Health Sciences, Inc. in 2014 Q4 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
+$900M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$90.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$81M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$44M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$32.2M |
Top Sellers
PRAH Hedge Fund Activity: Q4 2014 in Review
60 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2014, worth a combined $1.44B.
Buyers outnumbered sellers: 60 funds opened new PRAH positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Kohlberg Kravis Roberts & Co, opening a new position worth an estimated $900M.
- 60 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $1.44B of PRA Health Sciences, Inc. stock for Q4 2014.
- 60 funds opened new PRA Health Sciences, Inc. positions in Q4 2014 and 0 closed out, a net change of +60 holders.
- The largest PRA Health Sciences, Inc. buyer in Q4 2014 was Kohlberg Kravis Roberts & Co, an estimated $900M added.
Based on aggregated 13F filings for Q4 2014.